ONO 8610539
Alternative Names: ONO-8610539Latest Information Update: 28 Mar 2021
At a glance
- Originator Ono Pharmaceutical
- Class Anticoagulants; Antithrombotics; Small molecules
- Mechanism of Action Factor XIa inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Cerebral ischaemia
Most Recent Events
- 28 Mar 2021 No recent reports of development identified for preclinical development in Cerebral-ischaemia in Japan (IV)
- 22 Feb 2017 Preclinical trials in Cerebral ischaemia in Japan (IV) before February 2017
- 22 Feb 2017 Pharmacodynamics data from a preclinical study in Cerebral ischaemia released by Ono Pharmaceuticals